Fresenius Medical Care | FME - 流动负债

金融业

EUR

EUR 31.29B

现金及等价物

EUR 1.06B

EUR 3.55B

EUR 7.69B

EUR 7.18B

EUR 10.96B

股息收益率

3.76

EUR 480.55M

EUR 843.66M

112.38K

EPS每股收益

EUR 1.12

股本和储备

EUR 13.53B

EUR 1.31B

债务利息支出

EUR 83M

EUR 14.7M

EUR 5.82B

EUR 11.39B

EUR 218.38M

EUR 4.32B

EUR 537.27M

普通股股本

EUR 266.11M

12.13

EUR 383M

EUR 4.86B

销售和管理费用

EUR 736.01M

EUR 2.33B

贸易债权人

EUR 891.84M

应收帐款人

EUR 3.47B

	流动负债	更改		日
Akzo Nobel	EUR 4.31B		77M	2026-06
Alcon AG	USD 3.17B		163M	2026-06
AstraZeneca	USD 31.55B		1.02B	2026-06
Bayer	EUR 32.27B		1.19B	2026-06
Beiersdorf	EUR 3.51B		261M	2025-12
DaVita Healthcare Partners	USD 2.86B		12.03M	2026-06
Demant	DKK 12.42B		5B	2026-06
E.ON	EUR 27.97B		1.52B	2026-06
Essilor	EUR 12.64B		490M	2026-06
Fresenius	EUR 9.07B		468M	2026-06
Fresenius Medical Care	EUR 7.18B		448.03M	2026-06
Genmab	DKK 1.14B		38M	2026-06
Getinge	SEK 12.03B		3.01B	2026-06
Givaudan	CHF 2.35B		422M	2025-12
GlaxoSmithKline	GBP 21.53B		895M	2026-06
GN Store Nord	DKK 5.97B		1.15B	2026-06
GRIFOLS	EUR 2.24B		112M	2026-06
Hikma Pharmaceutical	USD 1.45B		603M	2025-12
Lonza	CHF 3.57B		421M	2025-12
Merck	EUR 8.12B		1.22B	2026-06
Novartis	USD 31.75B		374M	2026-06
Philips	EUR 7.42B		8M	2026-06
Roche Holding	CHF 28.85B		846M	2026-06
RWE	EUR 30.82B		5.42B	2026-06
Sanofi	EUR 31.93B		1.92B	2026-06
SAP	EUR 19.73B		1.09B	2026-06
Smith & Nephew	USD 2.05B		510M	2026-06